Search Ontology:
ChEBI
EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor
- Term ID
- CHEBI:74520
- Synonyms
-
- 6-phospho-D-gluconate dehydrogenase inhibitor
- 6-phospho-D-gluconate dehydrogenase inhibitors
- 6-phospho-D-gluconate:NADP+ 2-oxidoreductase (decarboxylating) inhibitor
- 6-phospho-D-gluconate:NADP+ 2-oxidoreductase (decarboxylating) inhibitors
- 6-phosphogluconate dehydrogenase (decarboxylating) inhibitor
- 6-phosphogluconate dehydrogenase (decarboxylating) inhibitors
- 6-phosphogluconic carboxylase inhibitor
- 6-phosphogluconic carboxylase inhibitors
- 6-phosphogluconic dehydrogenase inhibitor
- 6-phosphogluconic dehydrogenase inhibitors
- EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitors
- EC 1.1.1.44 inhibitor
- EC 1.1.1.44 inhibitors
- NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase (EC 1.1.1.44) inhibitor
- NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase (EC 1.1.1.44) inhibitors
- NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase inhibitor
- NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase inhibitors
- phosphogluconate dehydrogenase (NADP+ -dependent, decarboxylating) inhibitor
- phosphogluconate dehydrogenase (NADP+ -dependent, decarboxylating) inhibitors
- phosphogluconic acid dehydrogenase inhibitor
- phosphogluconic acid dehydrogenase inhibitors
- Definition
- An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase (EC 1.1.1.44).
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
- inverse has_role
-
Phenotype
Phenotype resulting from EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor
Phenotype where environments contain EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor
Phenotype modified by environments containing EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor
Human Disease Model